Open navigation
Search
Search

Select your region

Languages
  • Dutch
  • English

Dex Destombes is a member of the Corporate/M&A practice area group of our firm in Amsterdam. 

Dex advises on a broad range of domestic and cross‑border M&A transactions, acting for strategic buyers and sellers as well as financial sponsors. In addition to “traditional” M&A processes, Dex has a strong focus on private equity and venture capital transactions.

He regularly advises venture capital funds, founders and fast‑growing companies throughout the full investment lifecycle, from early‑stage and growth investments to exits, whether by way of a private share sale, IPO or otherwise.

Dex also has particular experience advising on M&A and investments in Life Sciences. He acts on transactions involving biotech, medtech and healthcare‑related businesses, often in complex and cross‑border settings.

Dex combines strong technical expertise with a pragmatic and commercial approach and works closely with CMS colleagues across jurisdictions on international mandates.

Education

  • Mergers and Acquisitions, Grotius Academy for Post-Graduate Law Studies
  • Master Dutch Law (Commercial Law Practice), University of Amsterdam

Insights by Dex

CMS advises a.s.r. on the acquisition of insurance activities Bovemij

02 Mar 2026 2 min read

CMS advises EuroEyes on the acquisition of FYEO

02 Mar 2026 2 min read

CMS advises Extantia on investment LeydenJar

11 Sep 2025 1 min read

CMS advises Talon on the acquisition of Out of Home Masters

22 Jan 2025 2 min read
Back to top Back to top